• LIVING WITH CRC

    Study Identifies Risk Factors for Serious Intestinal Side Effect With CAPOX Chemotherapy

    Researchers examined the incidence and risk factors of non-neutropenic enterocolitis—a serious intestinal inflammation—in colorectal cancer patients receiving adjuvant capecitabine and oxaliplatin (CAPOX) chemotherapy. (Clinical Colorectal Cancer)